与参与临床试验的公众伙伴开启关于估计目标的对话:一项共同开发的工具
该研究通过在线咨询会议与5名英国公众伙伴共同开发了一项用于解释估计目标的工具,并探索公众伙伴对在试验设计中讨论估计目标的看法。公众伙伴希望参与估计目标讨论,认为由研究者介绍该工具有助于开启对话,并建议采用讲故事、类比和视觉辅助。
要点
- 公众伙伴希望参与临床试验中估计目标的讨论。
- 共同开发的介绍性工具由研究者展示有助于开启估计目标对话。
- 公众伙伴建议工具中包含讲故事、类比和视觉辅助。
核心结论
- 研究团队与公众伙伴共同开发了一项工具,供研究者和公众伙伴使用,以促进公众伙伴参与估计目标讨论。
研究设计与样本
- 在线咨询会议,纳入5名来自英国不同地区、年龄、性别和族裔的公众伙伴,会议前由研究团队起草工具,会后完善并通过电子邮件收集反馈。
主要发现
- 公众伙伴希望参与估计目标讨论,并认为由研究者展示和描述的介绍性工具有助于在试验设计背景下开启关于估计目标的讨论。
- 公众伙伴建议工具中采用讲故事、类比和视觉辅助。
- 识别出与公众伙伴参与定义估计目标相关的四个主题:在试验中解决与患者和公众相关的问题的重要性、尽早让公众伙伴参与、所有利益相关者需要教育和沟通、公众伙伴与研究者合作。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical trials aim to draw conclusions about the effects of treatments, but a trial can address many different potential questions. For example, does the treatment work well for patients who take it as prescribed? Or does it work regardless of whether patients take it exactly as prescribed? Since different questions can lead to different conclusions on treatment benefit, it is important to clearly understand what treatment effect a trial aims to investigate-this is called the 'estimand'. Using estimands helps to ensure trials are designed and analysed to answer the questions of interest to different stakeholders, including patients and public. However, there is uncertainty about whether patients and public would like to be involved in defining estimands and how to do so. Public partners are patients and/or members of the public who are part of, or advise, the research team. We aimed to (i) co-develop a tool with public partners that helps explain what an estimand is and (ii) explore public partner's perspectives on the importance of discussing estimands during trial design. METHODS: An online consultation meeting was held with 5 public partners of mixed age, gender and ethnicities, from various regions of the UK. Public partner opinions were collected and a practical tool describing estimands, drafted before the meeting by the research team, was developed. Afterwards, the tool was refined, and additional feedback sought via email. RESULTS: Public partners want to be involved in estimand discussions. They found an introductory tool, to be presented and described to them by a researcher, helpful for starting a discussion about estimands in a trial design context. They recommended storytelling, analogies and visual aids within the tool. Four topics related to public partners' involvement in defining estimands were identified: (i) the importance of addressing questions that are relevant to patients and public in trials, (ii) involving public partners early on, (iii) a need for education and communication for all stakeholders and (iv) public partners and researchers working together. CONCLUSIONS: We co-developed a tool for researchers and public partners to use to facilitate the involvement of public partners in estimand discussions.
引用
- Cro S, Kahan BC, Patel A, et al. Starting a conversation about estimands with public partners involved in clinical trials: a co-developed tool. Trials. 2023. PMID: 37408080. doi:10.1186/s13063-023-07469-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。